Axsome Therapeutics Inc (NASDAQ: AXSM) stock enjoyed a major increase of 20.2% on 2/10/25. The shares closed at $127.08. Moreover, this advance was accompanied by exceptionally high trading volume at 479% of normal. The stock has risen 19.4% during the last week and has been strong relative to the market over the last nine months.
Current PriceTarget Research Rating
Axsome Therapeutics has a current Value Trend Rating of D (Negative). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Axsome Therapeutics has a very low Appreciation Score of 5 but a slightly positive Power Rating of 63, triggering the Negative Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment